MGMarta Gruszka

Marta Gruszka

*This is an algorithmically generated author record based on publicly available information.

Marta Gruszka has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adverse effects of oral glucocorticoid therapy - a brief review of literature

    by Marta Gruszka, Paulina Polańska, Maria Kubicka, Martyna Zakrocka, Jakub Fick

    Introduction and Objective: Glucocorticoids (GCs) are among the most commonly prescribed pharmaceuticals across various medical specialties. The purpose of this article is to provide an overview of the most common side effects of oral glucocorticoid therapy and to underline the importance of educating healthcare professionals and patients on this topic. State of knowledge: Glucocorticoids are commonly used in a wide range of patients because of their anti-inflammatory and immunosuppressive properties. Oral glucocorticoids can lead to a greater number of side effects in comparison with other routes of administration due to their systemic action. Adverse effects of glucocorticoid therapy involve endocrine, cardiovascular, musculoskeletal and central nervous systems. Patients often present with elevated serum glucose levels caused by reduced insulin sensitivity and amplified hepatic glucose production. Moreover, hyperglycemia and hypertension increase the risk of ischemic heart disease and heart failure. GCs impede bone formation and escalate bone resorption, resulting in bone mass reduction and osteoporosis. Myopathy may occur as a result of intensified catabolic processes. Glucocorticoid therapy impacts the production of cortisol by the adrenal glands and can lead to adrenal insufficiency and even adrenal crisis. Characteristic changes in external appearance aggravate self-esteem and mental health of patients resulting in decreased quality of life. Another adverse effect described in literature is substantial cognitive decline. Summary: Despite their multiple positive applications, glucocorticoids are associated with numerous side effects. It is imperative for medical professionals to ascertain that the disadvantages do not outweigh the advantages of glucocorticoid therapy. Further research is needed to ensure that patients are provided with the best possible care.


  • Open Access

    Cutaneous paraneoplastic syndromes. Dermatological manifestations associated with malignancies

    by Paulina Polańska, Marta Gruszka, Martyna Zakrocka, Maria Kubicka

    Introduction and purpose: Paraneoplastic syndromes (PS) are conditions associated with malignant tumours whose mechanism of onset is not fully understood. It is postulated that it’s pathophysiology may involve metabolic, endocrine, haematological changes and autoimmune reactions. The aim of this study is to describe cutaneous PS that nearly always occur with neoplasms. The work aims to give an overview of their clinical manifestations and to indicate the neoplasms they are most commonly associated with. Description of the state of knowledge: Several types of cutaneous PS are almost always associated with malignancies. These include conditions like acroceratosis paraneoplastica, paraneoplastic pemphigus, erythema gyratum repens, acquired hypertrichosis lanuginosa, necrolytic migratory erythema, tripe palms, and syndromes such as AESOP syndrome, ectopic ACTH syndrome, and carcinoid syndrome. These dermatoses present a wide range of clinical features, including skin lesions that vary in appearance, severity, and location, and they are linked to different types of tumors. The connection between cutaneous PS and underlying neoplasms involves various potential pathophysiological mechanisms. However, the exact processes driving these relationships remain unclear and are the subject of ongoing research. Conclusions: Awareness of cutaneous PS is crucial for early malignancy detection. Timely identification of these skin manifestations allows for quicker diagnosis and treatment of underlying neoplasm, significantly improving the patient's prognosis.


  • Open Access

    Analysis of poisoning with OTC drugs for suicidal purposes among children and adolescents in Poland in the period 2012 - 2023

    by Maria Kubicka, Paulina Polańska, Marta Gruszka, Martyna Zakrocka

    Introduction and Purpose: Drug poisoning among children and adolescents is an increasing public health issue worldwide and in Poland. Intentional poisonings, especially suicide attempts, are on the rise, often involving over-the-counter (OTC) medications, with paracetamol being the most commonly used substance. This paper aims to analyze the prevalence, characteristics, and implications of drug poisonings in youth, focusing on social and mental health factors, particularly during the COVID-19 pandemic. Materials and Methods: The study is based on retrospective data collected from Polish cities published between 2014 and 2023, examining hospital admissions, demographic trends, and poisoning agents. Results: The study reveals a significant increase in suicide attempts, especially during the COVID-19 pandemic. Paracetamol poisoning remains the leading cause of intentional overdoses, with severe cases potentially resulting in acute liver failure or death if untreated. Girls account for a disproportionate number of cases, and many adolescents who attempt suicide lack prior psychiatric diagnoses. Seasonal trends and shifts in age demographics suggest changing patterns in poisoning incidents. Conclusions: The findings emphasize the need for improved mental health education, early intervention, and caregiver awareness. Strengthening psychological support and implementing stricter regulation of OTC drugs are crucial to addressing the root causes of youth suicide attempts. Proactive measures, such as teaching problem-solving skills and expanding access to mental health services, are essential to mitigating this growing public health challenge.

  • Open Access

    Autism spectrum disorder: definition, global epidemiology, prevalence in Poland and worldwide, and heredity

    by Martyna Zakrocka, Marta Gruszka, Paulina Polańska, Maria Kubicka

    Introduction: The understanding of autism spectrum disorder (ASD) has evolved significantly. First mentioned in 1911, autism was described as "early childhood autism" by Leo Kanner in 1943, and a milder form, Asperger syndrome, was outlined by Hans Asperger in 1944. Expanding diagnostic criteria have led to increased recognition, with prevalence rising from 1 in 2,000 children in the 1980s to about 1 in 100 today. This growth is attributed to improved diagnostics, awareness, and healthcare access. While its exact causes remain unknown, ASD risk is influenced by genetic, environmental, prenatal, and perinatal factors, with genes like SHANK3, CHD8, and FMR1 playing key roles. The aim of the study: This study aims to provide a comprehensive overview of autism spectrum disorder by examining its definition, historical context, epidemiology, and heredity. Special attention is given to global prevalence rates, with a focus on comparative trends in Poland, as well as genetic advancements shaping our understanding of this condition. Material and method: In our article we used English databases such as PubMed and Google Scholar. We selected the articles according to keywords such as “ASD”, “autism”, “history of autism”, “epidemiology”, “inheritance”, “genetic”. The articles we used were published from 1943, mainly 2019-2024. Conclusions: ASD is a complex condition influenced by genetic and environmental factors. Advances in diagnostics and awareness have led to increased prevalence rates globally. Genetic studies highlight key hereditary components, offering insights for early intervention. Ongoing research and culturally tailored strategies are essential to improve diagnosis, support, and quality of life for individuals struggling with this condition.